| # | Drug | Count |
|---|---|---|
| 0 | LORAZEPAM | 18 |
| 1 | ALENDRONATE SODIUM | 17 |
| 2 | MONTELUKAST SODIUM | 17 |
| 3 | CISPLATIN | 16 |
| 4 | MEPOLIZUMAB | 16 |
| 5 | CICLESONIDE | 15 |
| 6 | ACLIDINIUM BROMIDE | 14 |
| 7 | ATORVASTATIN CALCIUM | 14 |
| 8 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 14 |
| 9 | HYDROCHLOROTHIAZIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 1 | ACLIDINIUM BROMIDE | 14 | 0.0022 |
| 2 | CEFOXITIN SODIUM | 2 | 0.0014 |
| 3 | CICLESONIDE | 15 | 0.0011 |
| 4 | FLUTAMIDE | 1 | 0.0010 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 6 | EPOETIN ALFA-EPBX | 1 | 0.0004 |
| 7 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 8 | TOBRAMYCIN SOLUTION | 4 | 0.0003 |
| 9 | TOBRAMYCIN SULFATE | 4 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 20 |
| 1 | Platinum-based Drug [EPC] | 19 |
| 2 | Interleukin-5 Antagonist [EPC] | 16 |
| 3 | Thiazide Diuretic [EPC] | 14 |
| 4 | Corticosteroid [EPC] | 13 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 6 | Loop Diuretic [EPC] | 9 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 8 | Aminoglycoside Antibacterial [EPC] | 7 |
| 9 | Calcium Channel Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Aminoglycoside Antibacterial [EPC] | 7 | 0.0002 |
| 3 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Vitamin K [EPC] | 1 | 0.0001 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 7 | Bile Acid [EPC] | 2 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |